Clinical trial to evaluate the effect of photobiomodulation on cognitive and psychological tests in patients with Alzheimer's disease

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20111121008146N35

Enrollment

Registered

2021-05-23

Start date

2021-04-30

Completion date

Unknown

Last updated

2021-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer. Alzheimer disease is a primary degenerative cerebral disease of unknown etiology with characteristic neuropathological and neurochemical features. The disorder is usually insidious in onset and develops slowly but steadily over a period of several years.

Interventions

Intervention 1: Intervention group: In addition to the usual treatment, they also use LEDs at home. Intervention 2: Control group: This group receives only the usual treatments.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Diagnosis of Alzheimer's disease by a neurologist

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
DADS Test. Timepoint: At the beginning and after the end of the laser course. Method of measurement: questionnaire.;MOCA Test. Timepoint: At the beginning and after the end of the laser course. Method of measurement: questionnaire.;Hamilton Test. Timepoint: At the beginning and after the end of the laser course. Method of measurement: questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Barati

Shahid Beheshti University of Medical Sciences

laser.cntr@yahoo.com+98 21 2271 8021

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026